Sources | Names Used |
---|---|
CTRPv2 | selumetinib:navitoclax (8:1 mol/mol) |
PharmacoGx | selumetinib:navitoclax (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-09 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | PIWIL4 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | METAP2 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-09 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
mRNA | RPS6KA1 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-09 |
mRNA | GPR75-ASB3 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-09 |
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-09 |